Beyond Meat Stock (NASDAQ:BYND), Trade Ideas

Beyond Meat

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Google -logo

News

Price Target

Markets

Trading Ideas

ACCD

BYND

FIVN

GOOGL

OCGN

TARA

Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

chart earnings

Long Ideas

Pre-Market Outlook

HPCO

Top 3 Risk Off Stocks That May Rocket Higher This Month

corporate bonds ai

Fintech news covering the emerging Financial Technology services sector

Fintech

Large Cap

Mid Cap

Bonds

Specialty ETFs

Small Cap

ETFs

ALLY

CVNA

LUMN

The U.S. corporate bond market had mixed performance in Q1, with higher-rated bonds seeing slight declines and lower-rated bonds showing modest gains. Top performers include Macy&#39;s, Ally Financial, and Lincoln National Corp.

Top 10 US Corporate Bonds By Market Performance In 2024: April Update

Beyond Meat Inc

BYND Cannasoft Enterprises Inc. - Common Stock

BYND Cannasoft Enterprises Inc

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.</p>
<p>Susquehanna raised the price target for <strong>Occidental Petroleum Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) from $70 to $81. Susquehanna analyst Biju Perincheril maintained a Positive rating. Occidental Petroleum shares rose 0.9% to close at $66.63 on Friday. <a href="https://www.benzinga.com/quote/OXY/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Keybanc boosted the price target for <strong>Alphabet Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) from $165 to $175. Keybanc analyst Justin Patterson maintained an Overweight rating. Alphabet shares fell 1.2% to close at $154.09 on Friday. <a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Chardan Capital increased <strong>Ocugen, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) price target from $4 to $5. Chardan Capital analyst Daniil Gataulin maintained a Buy rating. Ocugen shares closed at $1.32 on Friday. <a href="https://www.benzinga.com/quote/OCGN/analyst-ratings">See how other analysts view this stock.</a></p>
<p>Canaccord Genuity cut the price target for <strong>Five9, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) from $90 to $75. Canaccord Genuity analyst David Hynes maintained a Buy rating. Five9 shares fell 0.6% to close at $57.09 on Friday. <a href="https://www.benzinga.com/quote/FIVN/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Susquehanna increased <strong>ConocoPhillips</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) price target from $133 to $154. Susquehanna analyst Biju Perincheril maintained a Positive rating. ConocoPhillips shares rose 1.2% to close at $129.38 on Friday. <a href="https://www.benzinga.com/quote/COP/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Keybanc cut Meta<strong> Platforms, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) price target from $575 to $555. Keybanc analyst Justin Patterson maintained an Overweight rating. Meta shares fell 4.1% to close at $481.07 on Friday. <a href="https://www.benzinga.com/quote/META/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Stifel slashed the price target for <strong>Accolade, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) from $15 to $13. Stifel analyst David Grossman maintained a Buy rating. Accolade shares fell 0.4% to close at $9.13 on Friday. See how other analysts view this stock.</p>
<p>Oppenheimer raised <strong>Protara Therapeutics, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>) price target from $26 to $30. Oppenheimer analyst Leland Gershell maintained an Outperform rating. Protara Therapeutics shares fell 4% to close at $2.64 on Friday. <a href="https://www.benzinga.com/quote/TARA/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Mizuho slashed <strong>Beyond Meat, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) price target from $7 to $6. Mizuho analyst John Baumgartner maintained an Underperform rating. Beyond Meat shares rose 0.2% to close at $6.41 on Friday. <a href="https://www.benzinga.com/quote/BYND/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Morgan Stanley increased <strong>Alcoa Corporation</strong>  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) price target from $28.5 to $36.5. Morgan Stanley analyst Carlos De Alba upgraded the stock from Underweight to Equal-Weight. Alcoa shares rose 0.2% to close at $35.53 on Friday. <a href="https://www.benzinga.com/quote/AA/analyst-ratings">See how other analysts view this stock</a>.</p>
<p>Read More: <a href="https://www.benzinga.com/news/24/04/38350885/albertsons-companies-nucor-and-3-stocks-to-watch-heading-into-monday">Albertsons Companies, Nucor And 3 Stocks To Watch Heading Into Monday</a></p>


<p>Mizuho  analyst John Baumgartner   maintains Beyond Meat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) with a Underperform and lowers the price target from $7 to $6.</p>


Analyst Ratings

Mizuho Maintains Underperform on Beyond Meat, Lowers Price Target to $6

<p>The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.</p>
<p>Here's the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3 class="wp-block-heading" id="h-hempacco-co-inc-nasdaq-hpco"><strong>Hempacco Co., Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPCO#NASDAQ">HPCO</a>)</strong></h3>
<ul>
<li>On March 28, Hempacco signed three month media contract, for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The company's stock fell around 64% over the past month and has a <a href="https://www.benzinga.com/quote/HPCO">52-week low of $0.91</a>.</li>
<li><strong>RSI Value:</strong> 28.00</li>
<li><strong>HPCO Price Action:</strong> Shares of Hempacco gained 1% to close at $0.97 on Thursday.</li>
</ul>
<h3 class="wp-block-heading" id="h-walgreens-boots-alliance-inc-nasdaq-wba-nbsp-nbsp-nbsp-nbsp-nbsp-nbsp-nbsp-nbsp-nbsp-nbsp"><strong>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></h3>
<ul>
<li>On April 1, Morgan Stanley analyst Erin Wright maintained Walgreens with an Underweight and lowered the price target from $21 to $20. The company's stock fell around 15% over the past month. It <a href="https://www.benzinga.com/quote/WBA">has a 52-week low </a> of $17.51.</li>
<li><strong>RSI Value:</strong> 28.77</li>
<li><strong>WBA Price Action:</strong> Shares of Walgreens fell 0.2% to close at $17.59 on Thursday.</li>
</ul>
<h3 class="wp-block-heading" id="h-beyond-meat-inc-nasdaq-bynd"><strong>Beyond Meat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>)</strong></h3>
<ul>
<li>On March 18, Beyond Meat filed for a mixed securities shelf offering. The company's stock fell around 20% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/BYND">low of $5.58</a>.</li>
<li><strong>RSI Value:</strong> 29.61</li>
<li><strong>BYND Price Action:</strong> Shares of Beyond Meat fell 0.5% to close at $6.40 on Thursday.</li>
</ul>

<p>Read More: <a href="https://www.benzinga.com/news/earnings/24/04/38329059/netflix-procter-gamble-and-3-stocks-to-watch-heading-into-friday">Netflix, Procter &amp; Gamble And 3 Stocks To Watch Heading Into Friday</a></p>


<p><i>The new products are the company's meatiest, juiciest beef products yet, provide 21g of plant-based protein and are made with avocado oil, which offers heart-healthy monounsaturated fats, and helped lower the saturated fat to just 2g per serving</i><br /><br />&nbsp;</p>
<p><i>Consumers can find the new Beyond Burger and Beyond Beef, which are rolling out now in U.S. retail, by looking for the new eye-catching gold packaging</i></p>
<p>EL SEGUNDO, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>), a leader in plant-based meat, today announced the launch of the fourth generation Beyond Burger&#xAE; and Beyond Beef&#xAE;, the most significant renovation in the company's history, at grocery stores nationwide. The new Beyond Burger and Beyond Beef, the company's tastiest and most nutritious yet, are an excellent source of protein – 21g per serving – and have just 2g of saturated fat derived from avocado oil, with no cholesterol or added antibiotics or hormones. The products' meatier flavor and taste were preferred over the previous version in consumer testing1, and feedback on the new burger overall has been overwhelmingly positive. Additionally, at a recent conference of registered dietitians, 94% of attendees2 said they enjoyed the taste of the new Beyond Burger, viewed it as healthful, and would recommend it.</p>
<p>"I'm so excited about the new Beyond Burger and Beef because not only do they taste incredible, but they're super nutritious. Beyond Meat has switched to heart-healthy avocado oil, which brings the saturated fat in the burger and beef down to just 2 grams per serving, and they've also reduced the sodium from the previous version and simplified the ingredient list. I feel proud to recommend these products," said Joy Bauer, renowned registered dietitian, #1 NYT bestselling author and Beyond Meat nutrition advisor.</p>
<p><strong>Some of the key changes in the new Beyond Burger &amp; Beyond Beef:</strong></p>
<ul>
<li>Made with avocado oil – beloved by the nutrition community for its high levels of heart-healthy monounsaturated fats3, the shift to avocado oil helped reduce the saturated fat in the products by 60% to just 2g per serving (75% less than 80/20 beef)</li>
<li>Avocado oil's smoother, more neutral flavor also allowed Beyond Meat to unlock an even meatier, beefy flavor, and because avocado oil has a higher smoke point, the new beef is designed to sizzle and BBQ even better than before</li>
<li>Increased protein to 21g per serving</li>
<li>Added nutrient-dense plant-based ingredients including red lentil and faba bean protein</li>
<li>Simplified the ingredient list, including removing coconut and canola oils</li>
<li>20% less sodium vs. the previous version</li>
</ul>
<p>"The beefier flavor and texture of our new Beyond Burger and Beyond Beef make them the perfect option to use in a wide variety of recipes. They caramelize and brown beautifully when cooked, and offer the juicy, tender culinary experience of beef. From backyard BBQs to family taco nights, we've designed Beyond IV to not only be our meatiest, juiciest yet but to also be quick and easy to prepare so that everyone can Go Beyond," said Diana Stavaridis, Senior Culinary Manager, Beyond Meat.</p>
<p><i><strong>Growing portfolio of nutritious and delicious plant-based meat products</strong></i></p>
<p>The strong advancements in nutrition have qualified the fourth generation Beyond Burger and Beyond Beef products to be recognized by the nation's leading health organizations, including the American Diabetes Association's evidence-based nutritional guidelines for its Better Choices for Life program and being included in a <a href="https://www.globenewswire.com/Tracker?data=1AwuD1MB58EqFoMHlMtdpnSaMqG-4llDh510b6jEHJP11dbnW23sE4qEDcoyUFiQVxCCwwN5DRNJPRC6tVRzcase7X2aNayyfko8EdQfCdEVzwqEScW2hQNiBMQCggNqH77Mw6U71cEeOeCGHRW5CJZ8FRpCEuQ8oBsGmx2D6O9oCS6U0E3lChuD4CWkMbtt">collection of heart-healthy recipes</a> certified by the American Heart Association's Heart-Check program. Additionally, the new products have received Good Housekeeping's coveted Nutritionist Approved Emblem which assesses food products based on specific nutritional criteria as well as taste, simplicity, and transparency, and are the first plant-based meat products to be <a href="https://www.globenewswire.com/Tracker?data=11zAojWn7ThK2gJ-rephu-lhJeDPMIkcYUczJvynpV790h2eJi9We6wuDCoTyw7VLXaEK_m-MlW1_N0VZhYo4-m5iB6AxcvbXt3lDhyZDzrHhoNFdL6NfU6fmfAsKKlH">Clean Label Project Certified</a>. Developed in partnership with leading medical and nutrition experts, and designed to meet the standards of top health organizations, the making of the fourth generation Beyond Burger and Beyond Beef is being chronicled in a new documentary-style short film, <a href="https://www.globenewswire.com/Tracker?data=8OJtCIiOPbSqCFuq0bsjqBixuhkmUNrJzcW2rFd4NGqtY4Ww5IUKQhCw5yAsgnSjogYFUpLWqXW9Rue0FQl2AXIVDwdWTypd5magGeoLRkesUIxIcJ8bIzRMFjIttFyX"><i>Planting Change</i></a>, that will be released this summer.</p>
<p>The debut of Beyond IV follows the expansion of Beyond Meat's portfolio of nutritious and delicious products including <a href="https://www.globenewswire.com/Tracker?data=cloH6OjGbyfOGIHr-2-SRWLvX7d90o9v5kiDjc75QdJSfVf_pndvv16iE766YNEF8_xZkS15DWxxCpnV0zhuNBfi-O7EsNql7YgBcpjbCtEwO3g0eOICvXCQBP3MM1AXOHb7D0UdF-2kLXEWcD_RwSweMzMqzYlikzoa-HJ8lt8rgrpvOg8AUVhKfAEDcoBdLd9S28bYPlfsbNBzPfxLb09vTHXbtMYFj-gnXL6DEPIHp5Ub9HNDnGFu2XH5C-fkzKjOvAWrJ8dQSBHxXBahqvYxSl8qAFAw8_pmiUPsiXK6GYSgdjMno3BY6ZS3MdW11f2n3abVEM-jFqKhqD1HVofQxJGFWzelpN5OSe3pZAbPa06wLL1k8fuoxZ6ldf99">Beyond Crumbles</a> and <a href="https://www.globenewswire.com/Tracker?data=cloH6OjGbyfOGIHr-2-SRS4oGLmi3ZT-FzWegihJEbfY4oOEFlz9-w37UywyXyiN-dexTczxqS-W-v3DNl6ALhciVnEPZhnv0QbpIw_4n0pS1nWV4yLimrhhKT_pJt_ICRh5ce3J_ZYg9YqcJ62gXma2GOXeW18-xK7qSN7LOiDDgm9DO_WflO32_ejIZT12pyH0VezQHTHyJsv-r4aLbq4TFAQYTnUvzTzlwUzAgxs=">Beyond Steak</a><a href="https://www.globenewswire.com/Tracker?data=EDoISPg3LPPYiUdZV8LvcsEQNy0psKnEo62EwHrAkB8hf_-OasP0l-zl9B1yGBH62d4EfptJyZ5ReUahXFi6z0vWXaqdEdz1FP8FVkI3q9ORwqrnqE5DHE0_cbCVma2_6DqqgIpXk4sB9HD8tJY6jFPqQb-WFlbIsTwBaun9ngeX82Bakneok-_Rct3wPi5RTdJq7GZL79qZoI_XW6btVRlPSNTA-N6zIOytr3JDhBk=">&#xAE;</a> which are both certified by the American Heart Association's Heart-Check program and the American Diabetes Association's Better Choices for Life program. As part of its commitment to improving human health, Beyond Meat has a first-of-its-kind multi-year agreement with the <a href="https://www.globenewswire.com/Tracker?data=Uo-yXAnMjPXh_kYQoaUL5W7axQG0xNp_kZNLRssfqftvvaUj881degHUYGZ1BZOM2d7wCsKGWGvqAAqQv0CMSXANyhyvQrZRUHsJ0iBhZDKLy-ogz-elotNvATOPVccL--0tbGlWxfjmaG3DQyIZ60hqDb6WfVN2q3cpFbbf0nNSJBsWlO4pMjJv1pNrTxIRX-ImdrGcACr_g-ERknLyOj1Vk8u7N4D5NQTH3elofBw12HGNSRG504wlnZauKt-f">American Cancer Society</a> to advance research on plant-based meat and cancer prevention.</p>
<p>"We're proud to create products that allow you to Eat What You Love&#xAE;, like a juicy, delicious, sizzling burger, while offering health and environmental benefits to the consumer. We know that health is a top driver for the plant-based meat category, and with the advancements in taste and nutrition of our new Beyond Burger and Beyond Beef, we're giving consumers a really compelling reason to make the switch," said Akerho (AK) Oghoghomeh, Chief Marketing Officer, Beyond Meat.</p>
<p>Ready to try the new Beyond Burger and Beyond Beef for yourself? Find delicious recipes, cooking videos and more inspiration on the Beyond Meat <a href="https://www.globenewswire.com/Tracker?data=vxJKy5t5MUQyWNOwizsTGOOipKqYeb4PHiDwxXwavPgWfKdjqALKhlewyp4g68VA67EOPaAtcWOuj2P7lQxZ7-3XIGQcI-37A2QXYcfCb7I=">website</a>, with a new Beyond Meat cookbook expected to be released this summer. The new Beyond Burger and Beyond Beef in eye-catching gold packaging are rolling out now at major grocery chains nationwide including Walmart, Kroger, Albertsons, Publix, Whole Foods Market, Sprouts and more, visit the Beyond Meat <a href="https://www.globenewswire.com/Tracker?data=xh3oKJnTFaXqnDHhrL6d4e_5fbbiiyFq3-ElNYEVvPJjQ3wQrA010BaefWripbtybyzlP2fWiAbfgMZo50OWGUQFLyGg1pXTT-7nihq3773lLrAT3lFEMvQSTuUpksmpKlVA9GrvdUBtgspY3r3qXA==">store locator</a> to find the location nearest you.</p>


Beyond IV, The 4th Generation Of The Beyond Burger And Beyond Beef, Debuts At Grocery Stores Across the U.S. Including At Walmart And Kroger

<p>TD Cowen  analyst Robert Moskow   maintains Beyond Meat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) with a Sell and lowers the price target from $10 to $6.</p>


TD Cowen Maintains Sell on Beyond Meat, Lowers Price Target to $6

<p>The performance of the U.S. corporate bond market in the first quarter of the year was generally flat, though there were notable distinctions between the high-grade <a href="https://www.benzinga.com/money/high-yield-bonds">and high-yield sectors. </a></p>
<p>Bonds issued by companies with higher credit ratings (BBB and above) experienced a slight downward trajectory, as showed by the <strong>iShares iBoxx $ Investment Grade Corporate Bond ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LQD#NYSE">LQD</a>). Conversely, lower-rated companies boasting higher yields showed modestly positive performance, as indicated by the <strong>iShares iBoxx $ High Yield Corporate Bond ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYG#NYSE">HYG</a>).</p>
<p>Also Read: <a href="https://www.benzinga.com/news/large-cap/24/04/38098774/top-10-us-high-yield-corporate-bonds-with-returns-over-20-in-april-2024">Top 10 US High-Yield Corporate Bonds With Returns Over 20% In April 2024</a></p>
<p>Below is a list of U.S. corporate bonds that have exhibited the strongest performance in the last three months.</p>
<h3 class="wp-block-heading"><strong>10) Macy&#8217;s Retail Holdings LLC 4.3% 12/43</strong></h3>
<ul>
<li>Issuer: <strong>Macy&#8217;s Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>)</li>
<li>ISIN: US55616XAJ63</li>
<li>Last price: $82.08</li>
<li>Yield to maturity (%): 5.9712</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 15.83%</li>
</ul>
<h3 class="wp-block-heading">9) Ally Financial Inc. 4.7%</h3>
<ul>
<li>Issuer: <strong>Ally Financial Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>)</li>
<li>ISIN: US02005NBN93</li>
<li>Last price: $78.174</li>
<li>Type: subordinated</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 16.91%</li>
</ul>
<h3 class="wp-block-heading">8) Lincoln National Corp. 7.938% 06/66</h3>
<ul>
<li>Issuer: <strong>Lincoln National Corp</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNC#NYSE">LNC</a>)</li>
<li>ISIN: US534187AS84</li>
<li>Last price: $74.73</li>
<li>Maturity: 17/05/2066</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 17.87%</li>
</ul>
<h3 class="wp-block-heading">7) Carvana Co. 5.875% 20/28</h3>
<ul>
<li>Issuer: <strong>Carvana Co</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>)</li>
<li>ISIN: USU1468GAD61</li>
<li>Last price: $65.00</li>
<li>Yield to maturity (%): 18.1963</li>
<li>Maturity: 01/10/2028</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 20.37%</li>
</ul>
<h3 class="wp-block-heading">6) Braskem America Finance Co. 7.125% 11/41</h3>
<ul>
<li>Issuer: <strong>Braskem S.A.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>)</li>
<li>ISIN: USU1065PAA94</li>
<li>Last price: $90.85</li>
<li>Yield to maturity (%): 8.2834</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $200,000</li>
<li>3-month performance: 20.5%</li>
</ul>
<h3 class="wp-block-heading">5) M.D.C. Holdings Inc. 3.966% 21/61</h3>
<ul>
<li>Issuer: <strong>M.D.C. Holdings Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDC#NYSE">MDC</a>)</li>
<li>ISIN: US55616XAJ63</li>
<li>Last price: $82.08</li>
<li>Yield to maturity (%): 5.9712</li>
<li>Maturity: 15/02/2043</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 23.53%</li>
</ul>
<h3 class="wp-block-heading">4) QVC Inc. 5.95% 13/43</h3>
<ul>
<li>Issuer: <strong>QVC Inc.</strong></li>
<li>ISIN: US747262AM52</li>
<li>Last price: $64.53</li>
<li>Yield to maturity (%): 10.4849</li>
<li>Maturity: 15/03/2043</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 23.76%</li>
</ul>
<h3 class="wp-block-heading">3) At Home Group Inc. 4.875% 21/28</h3>
<ul>
<li>Issuer: <strong>At Home Group Inc.</strong></li>
<li>ISIN: USU04798AA90</li>
<li>Last price: $47.61</li>
<li>Yield to maturity (%): 27.4573</li>
<li>Maturity: 15/07/2028</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 26.38%</li>
</ul>
<h3 class="wp-block-heading">2) Lumen Technologies Inc. 4.5% 20/29</h3>
<ul>
<li>Issuer: <strong>Lumen Technologies Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>)</li>
<li>ISIN: USU1566PAD79</li>
<li>Last price: $36.32</li>
<li>Yield to maturity (%): 33.1453</li>
<li>Maturity: 15/01/2029</li>
<li>Minimum investment amount: $2,000</li>
<li>3-month performance: 27.01%</li>
</ul>
<h2 class="wp-block-heading">Chart: Lumen Technologies Bond Outperforms Lumen Shares In 2024</h2>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1024x495.png" alt="" class="wp-image-277973" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113118/image-8.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<h3 class="wp-block-heading">1) Beyond Meat Inc. 0.000% 21/27</h3>
<ul>
<li>Issuer: <strong>Beyond Meat Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>)</li>
<li>ISIN: US08862EAB56</li>
<li>Last price: $23.87</li>
<li>Maturity: 15/03/2027</li>
<li>Minimum investment amount: $1,000</li>
<li>3-month performance: 28.08%</li>
</ul>
<h2 class="wp-block-heading">Chart: Beyond Meat Bonds Outperform Shares In 2024</h2>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1024x495.png" alt="" class="wp-image-277986" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/04113716/image-9.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<h2 class="wp-block-heading"><strong>Why Have Beyond Meat Bonds Outperformed Shares?</strong></h2>
<p>Beyond Meat reported higher than expected revenue in the fourth quarter of 2023, yet suffered larger losses than anticipated. Following the earnings announcement, the company committed to significantly cutting costs and enhancing manufacturing efficiency. </p>
<p>These efforts improved the outlook on the company&#8217;s ability to fulfill its debt obligations, boosting investor confidence in Beyond Meat&#8217;s survival prospects, rather than reflecting a true turnaround in its long-term profitability.</p>
<p>Following its earnings report, Beyond Meat saw an initial market enthusiasm with rises in both bonds and shares. However, while bond values maintained their upward trajectory, the stock&#8217;s gains quickly dissipated, reversing the post-earnings uplift. </p>
<p>Since the beginning of the year, Beyond Meat&#8217;s zero-coupon bond, due to mature in March 2027, has seen a notable increase of 28%, contrasting with a roughly 6% drop in the company&#8217;s share price.</p>
<p>Read now: <em><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38091433/ai-revolution-is-underway-yet-its-economic-impact-is-several-years-off-goldman-sach">AI Revolution Is Underway, Yet Its Economic Impact Is &#8216;Several Years Off&#8217;: Goldman Sachs</a></em></p>
<p><em>Image generated using artificial intelligence via Midjourney.</em></p>


<p>Beyond Meat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>), a leader in plant-based meat, today announced a newly renovated and expanded line of Beyond Crumbles rolling out now in the freezer aisle at grocery stores across the U.S. The next generation of the company's plant-based crumbles will be available in three craveable flavors and have a good source of protein, are low in saturated fat, and meet the rigorous nutrition criteria of the American Heart Association's distinguished <a href="https://www.globenewswire.com/Tracker?data=BJG9VwrwzNu9FlVQP3wdUy9_uXSXIvfC4jTFXeKQQU7ZaiT5XwjGcyKgM4qaRINiGuy38BAbdPuup1oQuJ_PwTaiDKfXjPVq3x89iTK75qrnoxifpnbjvziXt7ObmfEr9y6zCnbxx4jt3SZGDuQl1iW9DQ6BOo3sH-J-BpRTVzV7tr8jBikxErvs7eG5p5am">Heart-Check Food Certification Program</a> and the American Diabetes Association's <a href="https://www.globenewswire.com/Tracker?data=m-Culw197jER9goATynZiXBPc3fuMnFycU2v4qWpmNVL4o4beVLexNwvG1gAWZhYUOfjJaKlDNnqSrT2mnnobbXQAwRZdU2altCFGAqOrDVVJrNo7g32Tu1-6w-8A_lk03G5dr2bEs4mawTVdKr6Yfy7RtqNHo22Ntp9JZdwmqc=">Better Choices for Life Program</a>.<br /><br />&nbsp;</p>
<p>Beyond Crumbles are juicy, bite-sized crumbles that go from frozen to finished in just a few minutes for a delicious and healthy protein option at breakfast, lunch or dinner. Made with clean and simple plant-based ingredients, Beyond Crumbles have 12g of protein per serving with less than 1g of saturated fat and no cholesterol – nutritionals that make it a heart-healthy1 food. These new plant-based crumbles will be available in three versatile flavors, Beyond Beef&#xAE; Crumbles Original, Beyond Beef&#xAE; Crumbles Feisty, and the newest flavor, Beyond Sausage&#xAE; Crumbles Italian-Style, which will be available this summer. Convenient and easy to prepare, simply sauté the crumbles for four minutes in a skillet before adding them to your favorite dish or sauce. From a <a href="https://www.globenewswire.com/Tracker?data=-C_HomcZigRsj2G-pfMDWtA1Y3uOuCxdHxjak5wn0jjh_ry7E8HETfqFcUPNMG8pqbv1HIBPUOAL1f6EDQWA9Yu7aOEBHgE7s8zZx5g3Mmg_apclWPYEM7yrXi75W6QuPleDjMcFSaJaw7AXL-8R5MbjgeQftl8vTSmyUoR2I2g=">Feisty Cauliflower Fundido</a> and rich <a href="https://www.globenewswire.com/Tracker?data=ckk-GVv_z3v79pYZjwXDhz4VHeGxsZl3HH2QBaAreVAXwdvjkeN-rGBnh_Qv9JVRANYFhoIc3tp-jexo4WUUiDphUt9GUaMWFbefl02IoFrTaYNk-E_kLcrOhH_nRndDjdidPRBoa7QlFgvOkr5n9jKMrzZb-BFcA-Su49ol3FE=">Sweet Potato Chili</a> to a hearty <a href="https://www.globenewswire.com/Tracker?data=kouSpq3PQDPx6mfO5EwlEQcuhHmiDFljzZxZS-taYVt_yu1bBENJodyj9-ReT46AP6F2KiBT6L7dVdPmRjMmcUmHqlSXI5iN0lVsEckNBepW6LHwReRh8d6sDhnXTA4J8AUKRWalRwNTMvo9aIkDO5Nd4xoUiCx-qSAbEStdgcI=">Mushroom Bolognese</a>, the crumbles are endlessly customizable to fit any recipe.</p>
<p>"We continue to innovate across our product lines to deliver delicious taste and health benefits alike. For consumers who love the taste and versatility of beef, but want to reduce saturated fat and cholesterol in their diet, Beyond Crumbles offer a convenient, healthy protein for the center of the plate. Beyond Crumbles' strong nutritional profile, coupled with its simple and clean ingredient list, earned the product certification by the American Heart Association's Heart-Check program and the American Diabetes Association's Better Choices for Life program," said Beyond Meat Founder and CEO Ethan Brown.</p>
<p>As part of Beyond Meat's commitment to innovating for human health, this announcement follows Beyond Steak's earlier certifications by the <a href="https://www.globenewswire.com/Tracker?data=c4lyc-cgkX-hPglthn6i69qTIZ0z7YfUfDFd2x-3hqAbjzEwfQBlzlCSoMVDjW6ag_OnS8XFr1XUeSZPjSKUVbKXRsnNeDEZ3izou3aFSk0OBJZOSao32xz12b8rzrxFiIBVg09_ZXlGHbsQ2GJ1jTNR53f0jQTXkBeYPWwF7rz-fExScXFY7zNTcQJHPCxOtAkFYX79_XEH4LrugycX3I_mbHEUXOqVQdqCY6drCSMpFKM189rloKwfpxjdNNQY">American Heart Association</a> and the <a href="https://www.globenewswire.com/Tracker?data=c4lyc-cgkX-hPglthn6i66hSdJfLF3YiZAOiST9CZEjsQ9xxQ0cHcx0jMXIu4HXi-sQNJM61ivY1BXGOGUVjsbhssr7Bw5DnWfqKo4moI-AYf1OBvIuL3AbVnu2YRwBCntqESRRjxSbl8uulmL_ED3yglHR4uz--OvEnwRdcSOvRbP971cnW1Np6ysqIJuJ1zDXUVZ0eMiDYbJFDhpfH7vHsnEcYWjvOjolwsHI7jA2leqswgZbY5kqXi20WdlxoEDinSzvn1g3NMS1CxzRujgUZKbCC7baGrZuNRwqZcpC3jWpdJOs3nlpblgKb0BI7">American Diabetes Association</a>. Additionally, the company recently announced its new <a href="https://www.globenewswire.com/Tracker?data=8nFqyROi2QtKAESovwIovn1d676OVfueViPq3PCIRc0hgYsm1dJ6MpnCk1XJ-jAynANvKrMhPeCovoPqDPecqGTmJyor4nrrDfqD3THFVT_pCH7X8f8NIYTdaPs3buDMmTLdek2cFwP58JXgc9LouzOyJGdqGfdRWGu1f73dVJHXDxLW2vXFx9LL8SR-H_mfXHzO-G2fYAmJTygvJH1DnRxlDMmJZUDC1C8U1w9HRtIbBr1kB3pLCtC2sjHBJlCO">Beyond IV platform</a>, the fourth generation of the Beyond Burger&#xAE; and Beyond Beef&#xAE;, with significant advancements across taste, health and clean label. The new Beyond IV products, which will launch at grocery stores across the U.S. this spring, are the result of a multi-year research effort that included working with leading medical and nutrition experts to meet the standards of top health organizations.</p>


Beyond Meat Unveils New And Expanded Line Of Beyond Crumbles, Now Certified By The American Heart Association's Heart-Check Program And The American Diabetes Association's Better Choices For Life Program

<p>Financial giants have made a conspicuous bearish move on Beyond Meat. Our analysis of options history for Beyond Meat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) revealed 12 unusual trades.</p>
<p>Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $1,434,648, and 4 were calls, valued at $123,677.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1.0 to $20.0 for Beyond Meat over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Beyond Meat's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Beyond Meat's substantial trades, within a strike price spectrum from $1.0 to $20.0 over the preceding 30 days.</p>
<h3>Beyond Meat Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1711476946_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$20.00</td>
<td>$296.4K</td>
<td>1.8K</td>
<td>485</td>
</tr>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$20.00</td>
<td>$250.7K</td>
<td>1.8K</td>
<td>1.0K</td>
</tr>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$20.00</td>
<td>$222.7K</td>
<td>1.8K</td>
<td>190</td>
</tr>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$20.00</td>
<td>$207.0K</td>
<td>1.8K</td>
<td>837</td>
</tr>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$6.00</td>
<td>$197.9K</td>
<td>3.7K</td>
<td>2.6K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Beyond Meat</h3>
<p>Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.</p>
<p>In light of the recent options history for Beyond Meat, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Beyond Meat Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,095,905, with BYND's price up by 1.13%, positioned at $8.02.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 43 days.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Beyond Meat, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Looking At Beyond Meat's Recent Unusual Options Activity

<p>Shares of <strong> Peraso Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prso#NASDAQ">PRSO</a>) fell sharply during Tuesday&rsquo;s session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/PRSO/earnings">fourth-quarter EPS results</a>.</p>
<p>Peraso posted a quarterly loss of $8.52 per share, versus analysts&rsquo; estimates for a loss of $3.76 per share. The company&rsquo;s quarterly sales came in at $1.83 million versus expectations of $1.70 million.</p>
<p>Peraso shares tumbled 23.3% to $1.32 on Tuesday.</p>
<p>Here are some other stocks moving in today&#39;s mid-day session.</p>
<h3><strong>Gainers</strong></h3>
<ul>
<li><strong>Ontrak, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otrk#NASDAQ">OTRK</a>) shares climbed 197.8% to $0.5660 ahead of the company&#39;s presentation at the 36th Annual Roth Conference.</li>
<li><strong>Fusion Pharmaceuticals Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fusn#NASDAQ">FUSN</a>) gained 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21.</li>
<li><strong>SCWorx Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/worx#NASDAQ">WORX</a>) gained 74% to $3.22.</li>
<li><strong>Spire Global, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spir#NYSE">SPIR</a>) climbed 50.7% to $18.50 after announcing a collaboration with NVIDIA to advance AI-driven weather prediction.</li>
<li><strong>Enveric Biosciences, Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envb#NASDAQ">ENVB</a>) shares climbed 43.6% to $1.5801 after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases.</li>
<li><strong>Zoomcar Holdings, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcar#NASDAQ">ZCAR</a>) rose 33.1% to $1.57 after the company announced that it partnered with EaseMyTrip to integrate its cars within the travel platform.</li>
<li><strong>Hoth Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hoth#NASDAQ">HOTH</a>) surged 32% to $1.51 after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer&#39;s disease.</li>
<li><strong>Enliven Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elvn#NASDAQ">ELVN</a>) gained 27.2% to $16.09. The company announced a $90 million private placement financing and provided pipeline updates.</li>
<li><strong>National CineMedia, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncmi#NASDAQ">NCMI</a>) gained 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million.</li>
<li><strong>Alignment Healthcare, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alhc#NASDAQ">ALHC</a>) gained 17.7% to $5.50.</li>
<li><strong>Crinetics Pharmaceuticals, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crnx#NASDAQ">CRNX</a>) rose 15% to $43.63 after the company&#39;s Phase 3 PATHFNDR-2 trial of paltusotine in acromegaly achieved the primary and all secondary endpoints.</li>
<li><strong>Li-Cycle Holdings Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/licy#NASDAQ">LICY</a>) climbed 14% to $1.2540 after the company announced progress in improving its current liquidity position and it is conducting an internal technical review of the Rochester Hub.</li>
<li><strong>Verb Technology Company, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) gained 12.5% to $0.4055 after falling over 18% on Monday. The company on Friday announced its Market.live launched Facebook and Instagram social shopping technology integration.</li>
<li><strong>Monopar Therapeutics Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnpr#NASDAQ">MNPR</a>) climbed 12% to $0.75.</li>
<li><strong>Nordstrom, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jwn#NYSE">JWN</a>) gained 11.9% to $19.10 following a report suggesting the company&#39;s founding family is working with Morgan Stanley and Centerview Partners in an attempt to potentially go private.</li>
<li><strong>Alpine Immune Sciences, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alpn#NASDAQ">ALPN</a>) gained 10.3% to $39.13 following fourth-quarter earnings.</li>
<li><strong>Nocturne Acquisition Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbtc#NASDAQ">MBTC</a>) rose 10% to $11.00.</li>
<li><strong>DocGo Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcgo#NASDAQ">DCGO</a>) gained 10% to $4.0550. DocGo announced repurchases of common stock and adoption of 10b5-1 trading plan for share repurchase program.</li>
<li><strong>Augmedix, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/augx#NASDAQ">AUGX</a>) gained 9.3% to $3.6399 following upbeat fourth-quarter results.</li>
<li><strong>International Paper Company</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ip#NYSE">IP</a>) climbed 7% to $37.38. International Paper said it has elected Andrew Silvernail as Chief Executive Officer, following an extensive evaluation process.</li>
</ul>
<h3><strong>Losers</strong></h3>
<ul>
<li><strong>Greenwave Technology Solutions, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwav#NASDAQ">GWAV</a>) shares fell 56.2% to $0.1634. The company announced it has restructured its senior secured debt.</li>
<li><strong>Seelos Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seel#NASDAQ">SEEL</a>) fell 46.6% to $0.4901 after the company announced that its ALS study with SLS-005 did not meet statistical significance in the primary and secondary endpoint in the Full Analysis Set.</li>
<li><strong>Comtech Telecommunications Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmtl#NASDAQ">CMTL</a>) dipped 26.7% to $3.37 following weak quarterly results.</li>
<li><strong>Solowin Holdings</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) declined 24.7% to $5.80. The company reported H1 2024 financial results.</li>
<li><strong>NuScale Power Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) fell 23.8% to $7.69 after Wells Fargo downgraded the stock from Equal-Weight to Underweight and lowered its price target from $7.50 to $4.50.</li>
<li><strong>Acutus Medical, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afib#NASDAQ">AFIB</a>) fell 21.6% to $0.2055 after surging 34% on Monday. Acutus Medical was granted European patent number EP3294412 titled &quot;Localization System And Method Useful In The Acquisition and Analysis of Cardiac Information (For Diagnosis And Treatment Of Cardiac Abnormalities).&quot;</li>
<li><strong>Zepp Health Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zepp#NYSE">ZEPP</a>) declined 17.2% to $1.01 following quarterly results.</li>
<li><strong>HUYA Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/huya#NYSE">HUYA</a>) fell 15.5% to $3.9887 after it reported fourth-quarter FY23 revenue of $215.5 million, beating the consensus of $210.04 million.</li>
<li><strong>Chijet Motor Company, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjet#NASDAQ">CJET</a>) shares fell 15.4% to $0.49 after gaining 18% on Monday.</li>
<li><strong>MicroStrategy Incorporated </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) shares tumbled 14.8% to $1,279.85 amid a pullback in Bitcoin. MicroStrategy shares dipped over 15% on Monday after the company recently announced pricing of its offering of convertible senior notes.</li>
<li><strong>DLocal Limited</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dlo#NASDAQ">DLO</a>) shares tumbled 14.3% to $15.54 after the company reported mixed fourth-quarter financial results, issued guidance and announced a new CFO.</li>
<li><strong>ACM Research, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acmr#NASDAQ">ACMR</a>) fell 13.5% to $24.76.</li>
<li><strong>ShiftPixy, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) fell 13.3% to $5.89 after gaining 100% on Monday.</li>
<li><strong>CleanSpark, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) dipped 12.7% to $15.23 amid a pullback in Bitcoin.</li>
<li><strong>JOANN Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/joan#NASDAQ">JOAN</a>) fell 12.7% to $0.1597 after dipping 20% on Monday. JOANN announced that it entered into an agreement to reduce its debt and receive $132 million in new capital and related financial accommodations.</li>
<li><strong>Super Micro Computer, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) dipped 12.2% to $878.99 after the company announced the launch of a proposed public offering of 2,000,000 shares of its common stock.</li>
<li><strong>JOYY Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yy#NASDAQ">YY</a>) fell 11.6% to $29.50. JOYY posted upbeat earnings for its fourth quarter. The company said it sees first-quarter net revenues of $543 million to $560 million versus market estimates of $579.45 million.</li>
<li><strong>Direct Digital Holdings, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) fell 11.4% to $25.58.</li>
<li><strong>GigaCloud Technology Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gct#NYSE">GCT</a>) fell 11.3% to $30.33.</li>
<li><strong>StoneCo Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stne#NASDAQ">STNE</a>) shares fell 9.4% to $15.82 after the company reported fourth-quarter financial results.</li>
<li><strong>Marathon Digital Holdings, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) fell 8.7% to $17.70 amid a pullback in Bitcoin.</li>
<li><strong>Coinbase Global, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) shares fell 8.1% to $220.14 amid weakness in Bitcoin prices.</li>
<li><strong>Portage Biotech Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtg#NASDAQ">PRTG</a>) shares fell 7.8% to $0.53 after gaining around 5% on Monday.</li>
<li><strong>Beyond Meat, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) shares declined 7.3% to $7.70 after the company filed for a mixed securities shelf offering.</li>
<li><strong>SoundHound AI, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) fell 5.8% to $7.76. The company launched an innovative in-vehicle voice assistant today.</li>
<li><strong>Bitdeer Technologies Group</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btdr#NASDAQ">BTDR</a>) shares dipped 5.6% to $6.99. Bitdeer Technologies Group filed for mixed shelf of up to $750 million.</li>
</ul>
<p>&nbsp;</p>
<p>Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37819814/around-9m-bet-on-cardlytics-check-out-these-4-stocks-insiders-are-buying"><em> Around $9M Bet On Cardlytics? Check Out These 4 Stocks Insiders Are Buying</em></a></p>


Penny Stocks

Intraday Update

Movers

ACMR

AFIB

ALHC

ALPN

AUGX

BTDR

CJET

CLSK

CMTL

COIN

CRNX

DCGO

DRCT

ELVN

ENVB

FUSN

GWAV

HOTH

HUYA

JOAN

LICY

MARA

MBTC

MNPR

MSTR

NCMI

OTRK

PIXY

PRSO

PRTG

SEEL

SMCI

SOUN

SPIR

STNE

SWIN

VERB

WORX

ZCAR

ZEPP

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

<p><strong>Beyond Meat Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) shares are trading lower Tuesday&nbsp;after the company filed for a&nbsp;<a href="https://www.benzinga.com/news/offerings" target="_blank" rel="noreferrer noopener">mixed securities shelf offering</a>.</p>
<p><strong>What To Know: </strong>After the market close on Monday, Beyond Meat said in a filing that it may offer and sell up to&nbsp;$250 million of securities from time to time in one or more offerings. The securities available may include common stock, preferred stock, debt securities, warrants, purchase contracts or units.&nbsp;</p>
<p>Beyond Meat <a href="https://www.benzinga.com/news/earnings/24/02/37348722/beyond-meat-q4-earnings-revenue-beat-eps-miss-business-reset-and-more">reported earnings</a> at the end of February. The plant-based meat company said it had $205.9 million in cash, cash equivalents and restricted cash and $1.1 billion in debt as of Dec. 31.</p>
<p>Beyond Meat shares have underperformed the broader market in recent years. The stock is down about 45% over a one-year period.</p>
<p><em>See Also: <a href="https://www.benzinga.com/markets/equities/24/03/37819791/whats-going-on-with-soundhound-stock-tuesday">What&#8217;s Going On With SoundHound Stock Tuesday?</a></em></p>
<h2 class="wp-block-heading">Should I Sell My BYND Stock?</h2>
<p>Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.</p>
<p>Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.</p>
<p>Shares of Beyond Meat have lost 48.98% year to date. This compares to the average annual return of -60.93%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. </p>
<p>Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Beyond Meat stock currently has an RSI of 49.6, indicating neutral conditions.</p>
<p>For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a></p>
<p><strong>BYND Price Action:</strong> <a href="https://www.benzinga.com/quote/BYND">Beyond Meat shares</a> were down 4.81% at $7.91 at the time of writing, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. </p>
<p><em>Photo: courtesy of Beyond Meat.</em></p>


Offerings

What's Going On With Beyond Meat Stock?

WIIM

Beyond Meat shares are trading lower after the company filed for a mixed securities shelf offering.

<p>U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Tuesday.</p>
<p>Shares of <strong> DLocal Limited</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dlo#NASDAQ">DLO</a>) fell sharply in today&rsquo;s pre-market trading after the company reported mixed fourth-quarter financial results, issued guidance and <a href="https://www.benzinga.com/news/earnings/24/03/37801639/dlocal-stock-falls-on-mixed-q4-results-eps-miss-revenue-beat">announced a new CFO</a>.</p>
<p>DLocal reported quarterly earnings of 10 cents per share which missed the analyst consensus estimate of 15 cents by 33.33%. The company reported quarterly sales of $188 million, beating the analyst consensus estimate of $173.686 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.</p>
<p>The company announced the appointment of Mark Ortiz as dLocal&rsquo;s Chief Financial Officer, effective April 15.</p>
<p>DLocal shares dipped 13.3% to $15.77 in pre-market trading.</p>
<p>Here are some big stocks recording losses in today&rsquo;s pre-market trading session.</p>
<ul>
<li><strong>StoneCo Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stne#NASDAQ">STNE</a>) shares dipped 9.8% to $15.75 in pre-market trading after the company reported fourth-quarter financial results.</li>
<li><strong>MicroStrategy Incorporated </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) shares fell 9.2% to $1,365.00. MicroStrategy shares dipped over 15% on Monday after the company recently announced pricing of its offering of convertible senior notes.</li>
<li><strong>Bitdeer Technologies Group</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btdr#NASDAQ">BTDR</a>) shares dipped 8.4% to $6.78 in pre-market trading. Bitdeer Technologies Group filed for mixed shelf of up to $750 million.</li>
<li><strong>Beyond Meat, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) shares declined 7.9% to $7.65 in pre-market trading after the company filed for a mixed securities shelf offering.</li>
<li><strong>Brand Engagement Network, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnai#NASDAQ">BNAI</a>) shares fell 6.2% to $12.90 in pre-market trading after surging over 30% on Monday.</li>
<li><strong>Coinbase Global, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) shares fell 5.4% to $226.69 in pre-market trading amid weakness in Bitcoin prices.</li>
<li><strong>CleanSpark, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) shares declined 5.3% to $16.54 in pre-market trading. BTIG analyst Gregory Lewis maintained Cleanspark with a Buy and raised the price target from $12 to $22.</li>
<li><strong>PagSeguro Digital Ltd.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pags#NYSE">PAGS</a>) shares fell 3.5% to $13.58 in pre-market trading. On Monday, New Street Research analyst Soomit Datta upgraded PagSeguro Digital from Neutral to Buy and announced an $18 price target.</li>
</ul>
<p>&nbsp;</p>
<p>Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37811836/investor-optimism-decreases-ahead-of-fed-meeting-s-p-snaps-3-session-losing-streak"><em> Investor Optimism Decreases Ahead Of Fed Meeting; S&amp;P Snaps 3-Session Losing Streak </em></a></p>
<p><em>Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a></em></p>


BNAI

PAGS

DLocal Posts Mixed Q4 Results, Joins StoneCo, Beyond Meat And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

<p><strong>Beyond Meat Inc </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) shares are trading lower in Monday&#8217;s after-hours session after the company filed for a <a href="https://www.benzinga.com/news/offerings">mixed securities shelf offering</a>.</p>
<p><strong>What Happened: </strong>After the market close on Monday, Beyond Meat said it may offer and sell up to&nbsp;$250 million of securities from time to time in one or more offerings. The securities available may include common stock, preferred stock, debt securities, warrants, purchase contracts or units. </p>
<p>Beyond Meat just reported earnings at the end of February. The company said it had $205.9 million in cash, cash equivalents and restricted cash and $1.1 billion in debt as of Dec. 31.</p>
<p>Beyond Meat shares have underperformed the broader market in recent years. The stock got a lift from earnings last month, but it had already given back most of its gains. Beyond Meat shares are down about 45% over a one-year period.</p>
<p><em>Check This Out: <a href="https://www.benzinga.com/news/24/03/37790696/is-reddits-ipo-another-moon-right-away-story-like-rivian-beyond-meat">Is Reddit&#8217;s IPO Another &#8216;Moon Right Away&#8217; Story Like Rivian, Beyond Meat?</a></em></p>
<h1 class="wp-block-heading"><strong>BYND Stock Prediction 2024</strong></h1>
<p>Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.</p>
<p>Shares of Beyond Meat have an average one-year price target of $8.50, representing an expected upside of 2.29% from current levels.</p>
<p>Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. <strong>The street high price target from BMO Capital is $10, while the street low from Mizuho is $7.</strong></p>
<p><strong>BYND Price Action:</strong> Beyond Meat shares were down 6.14% after hours at $7.80 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37794796/ai-stocks-rally-ahead-of-nvidias-woodstock-analysts-eye-next-phases-for-growth">AI Stocks Rally Ahead Of Nvidia&#8217;s &#8216;Woodstock&#8217;: Analysts Eye Next Phases For Growth</a></em></p>
<p><em>Photo: Courtesy of Beyond Meat.</em></p>


After-Hours Center

Beyond Meat Stock Is Falling After Hours: What's Happening?

<p><strong>Reddit Inc</strong>&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) upcoming initial public offering (IPO), expected on March 21, has investors bracing themselves for what could be a turbulent ride in <a href="https://www.benzinga.com/topic/reddit">the stock market</a>. </p>
<p><strong>What Happened</strong>: <a href="https://www.benzinga.com/news/24/03/37769049/reddits-ipo-sparks-huge-interest-targeting-6-5-billion-valuation-says-report">The news that Reddit&#8217;s IPO</a> is between four and five times oversubscribed has stirred both excitement and skepticism among market participants. For example, some Reddit users are drawing parallels to past IPOs like <strong>Rivian Automotive Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) and <strong>Beyond Meat Inc </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>). </p>
<p>Both companies underperformed after their respective IPOs.  </p>
<p>Reddit is aiming for a $6.5 billion valuation — $10 billion less than the valuation it achieved for its last fundraising round in August 2021.</p>
<p><em>Related</em>: <em><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37678347/reddits-ipo-buzz-bullish-on-rddt-vs-immediate-short">Reddit&#8217;s IPO Buzz &#8211; &#8216;Bullish On RDDT&#8217; Vs. &#8216;Immediate Short&#8217;</a></em></p>
<p>While some see the oversubscription as a bullish sign, others remain cautious, citing the prevailing negativity surrounding the IPO within Reddit communities. </p>
<p>Despite concerns, there&#8217;s speculation that the social media platform could experience a surge in its stock price, fueled by the frenzy of retail investors eager to participate in a high-profile IPO.</p>
<p>We looked at responses as Redditors discussed the oversubscription and offered their insights on it.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-reddit wp-block-embed-reddit"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="reddit-embed-bq" style="height:316px" ><p><a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/reuters_reddits_ipo_as_much_as_five_times/">[Reuters] Reddit&#8217;s IPO as much as five times oversubscribed, sources say</a><br /> by<a href="https://www.reddit.com/user/Jeff__Skilling/">u/Jeff__Skilling</a> in<a href="https://www.reddit.com/r/stocks/">stocks</a></p></blockquote>
<script async src="https://embed.reddit.com/widgets.js" charset="UTF-8"></script></div>
<p></p></figure></p>
<h2 class="wp-block-heading">Will Reddit Stock &#8216;Moon Right Away&#8217;?</h2>
<p>One Redditor expressed confidence in Reddit&#8217;s potential, suggesting that the platform could defy expectations and soar in its market debut.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-reddit wp-block-embed-reddit"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="reddit-embed-bq" ><p><a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/comment/kvc1ir6/">Comment</a><br /> by<a href="https://www.reddit.com/user/Jeff__Skilling/">u/Jeff__Skilling</a> from discussion<a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/reuters_reddits_ipo_as_much_as_five_times/"><no value></no></a><br /> in<a href="https://www.reddit.com/r/stocks/">stocks</a></p></blockquote>
<script async src="https://embed.reddit.com/widgets.js" charset="UTF-8"></script></div>
<p></p></figure></p>
<p>However, some Reddit users recall how both the Rivian and Beyond Meat IPOs initially saw astronomical valuations before facing subsequent downturns.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-reddit wp-block-embed-reddit"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="reddit-embed-bq" ><p><a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/comment/kvds888/">Comment</a><br /> by<a href="https://www.reddit.com/user/Jeff__Skilling/">u/Jeff__Skilling</a> from discussion<a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/reuters_reddits_ipo_as_much_as_five_times/"><no value></no></a><br /> in<a href="https://www.reddit.com/r/stocks/">stocks</a></p></blockquote>
<script async src="https://embed.reddit.com/widgets.js" charset="UTF-8"></script></div>
<p></p></figure></p>
<p>The sentiment among investors appears divided. While some are planning to capitalize on the IPO&#8217;s volatility through options trading, others are adopting a wait-and-see approach. </p>
<p>Interestingly, Reddit&#8217;s decision to offer shares to its users has been hailed as a strategic move, tapping into the platform&#8217;s dedicated user base.</p>
<p><em>Related: <a href="https://www.benzinga.com/news/24/03/37482430/from-hating-reddit-ipo-to-shorting-the-stock-a-polarizing-debate-emerges-among-redditors?utm_campaign=partner_feed&amp;utm_source=InvestingUK&amp;utm_medium=partner_feed&amp;utm_content=TopStories">From Hating Reddit IPO To Shorting The Stock: A Polarizing Debate Emerges Among Redditors</a></em></p>
<h2 class="wp-block-heading">Will You Be Purchasing Puts Too?</h2>
<p>However, concerns linger regarding Reddit&#8217;s profitability and the potential impact of higher interest rates on its stock performance. Some investors are considering purchasing puts, anticipating a downturn in Reddit&#8217;s stock price post-IPO.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-reddit wp-block-embed-reddit"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="reddit-embed-bq" ><p><a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/comment/kvc5nfe/">Comment</a><br /> by<a href="https://www.reddit.com/user/Jeff__Skilling/">u/Jeff__Skilling</a> from discussion<a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/reuters_reddits_ipo_as_much_as_five_times/"><no value></no></a><br /> in<a href="https://www.reddit.com/r/stocks/">stocks</a></p></blockquote>
<script async src="https://embed.reddit.com/widgets.js" charset="UTF-8"></script></div>
<p></p></figure></p>
<p><figure class="wp-block-embed is-type-rich is-provider-reddit wp-block-embed-reddit"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="reddit-embed-bq" ><p><a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/comment/kvcjo71/">Comment</a><br /> by<a href="https://www.reddit.com/user/Jeff__Skilling/">u/Jeff__Skilling</a> from discussion<a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/reuters_reddits_ipo_as_much_as_five_times/"><no value></no></a><br /> in<a href="https://www.reddit.com/r/stocks/">stocks</a></p></blockquote>
<script async src="https://embed.reddit.com/widgets.js" charset="UTF-8"></script></div>
<p></p></figure></p>
<p><figure class="wp-block-embed is-type-rich is-provider-reddit wp-block-embed-reddit"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="reddit-embed-bq" ><p><a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/comment/kvc2v62/">Comment</a><br /> by<a href="https://www.reddit.com/user/Jeff__Skilling/">u/Jeff__Skilling</a> from discussion<a href="https://www.reddit.com/r/stocks/comments/1bh7gnx/reuters_reddits_ipo_as_much_as_five_times/"><no value></no></a><br /> in<a href="https://www.reddit.com/r/stocks/">stocks</a></p></blockquote>
<script async src="https://embed.reddit.com/widgets.js" charset="UTF-8"></script></div>
<p></p></figure></p>
<p>Reddit&#8217;s IPO is poised to make waves in the stock market. Whether it will be a success story or a cautionary tale remains to be seen. But one thing is for sure – investors are in for an eventful ride.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37678347/reddits-ipo-buzz-bullish-on-rddt-vs-immediate-short?utm_campaign=partner_feed&amp;utm_source=InvestingUK&amp;utm_medium=partner_feed&amp;utm_content=TopStories">Reddit&#8217;s IPO Buzz: &#8216;Bullish On RDDT&#8217; Vs. &#8216;Immediate Short&#8217;</a></em></p>
<p><em>Image: Shutterstock</em></p>


Social Media

IPOs

RDDT

RIVN

Is Reddit's IPO Another 'Moon Right Away' Story Like Rivian, Beyond Meat?

<p>Shares of <strong> Bitdeer Technologies Group </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btdr#NASDAQ">BTDR</a>) rose sharply during Monday&rsquo;s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.</p>
<p>Bitdeer Technologies Group shares jumped 10.2% to $7.45 on Monday.</p>
<p>Here are some other stocks moving in today&#39;s mid-day session.</p>
<h3><strong>Gainers</strong></h3>
<ul>
<li><strong>BitFuFu Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fufu#NASDAQ">FUFU</a>) shares jumped 107% to $13.20 amid volatility following the company&#39;s recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.</li>
<li><strong>Quoin Pharmaceuticals, Ltd. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) climbed 89% to $5.31 after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.</li>
<li><strong>Renalytix Plc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) gained 52.8% to $1.5890 after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.</li>
<li><strong>Phunware, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) climbed 42.7% to $10.11. Phunware is expected to report fourth-quarter results on March 12, 2024.</li>
<li><strong>Ainos, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) gained 39.4% to $1.4650.</li>
<li><strong>Jaguar Health, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jagx#NASDAQ">JAGX</a>) shares climbed 38.2% to $0.1223 after surging 50% on Friday.</li>
<li><strong>Cardiff Oncology, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) rose 31.6% to $3.83 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.</li>
<li><strong>The E.W. Scripps Company</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssp#NASDAQ">SSP</a>) gained 31.3% to $4.94. E.W. Scripps Director Charles L. Barmonde acquired a total of 10,500 shares an average price of $4.28.</li>
<li><strong>Helius Medical Technologies, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsdt#NASDAQ">HSDT</a>) climbed 30% to $5.91. Helius Medical Technologies announced it secured HCPCS codes for portable neuromodulation stimulator mouthpiece and controller.</li>
<li><strong>Kineta, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ka#NASDAQ">KA</a>) gained 27% to $1.14. Kineta recently announced a restructuring and the exploration of strategic alternatives.</li>
<li><strong>BigBear.ai Holdings, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) rose 25% to $4.3472.</li>
<li><strong>Critical Metals Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crml#NASDAQ">CRML</a>) gained 24.4% to $12.44.</li>
<li><strong>Ocean Biomedical, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) gained 22% to $2.44.</li>
<li><strong>Reliance Global Group, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) rose 21.7% to $0.6299 after gaining 11% on Friday.</li>
<li><strong>Akero Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akro#NASDAQ">AKRO</a>) climbed 21.1% to $33.69 after gaining 3% on Friday.</li>
<li><strong>89bio, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etnb#NASDAQ">ETNB</a>) gained 20.3% to $15.18.</li>
<li><strong>Nektar Therapeutics</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktr#NASDAQ">NKTR</a>) gained 19.4% to $0.9315. Nektar Therapeutics announced a $30 million private placement financing with TCGX.</li>
<li><strong>Super Micro Computer, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) shares gained 18.9% to $1,076.45. Super Micro Computer will join the S&amp;P 500 Index, effective March 18, S&amp;P Dow Jones Indices, a division of S&amp;P Global, said in a release.</li>
<li><strong>MicroStrategy Incorporated</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 17.8% to $1,271.51 amid strength in Bitcoin.</li>
<li><strong>Macy&#39;s, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) rose 16.3% to $20.95 after Arkhouse and Brigade Capital increased their offer to acquire Macy&#39;s to $24 per share.</li>
<li><strong>Renovaro Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/renb#NASDAQ">RENB</a>) gained 14.3% to $2.64.</li>
<li><strong>Digital World Acquisition Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) gained 13.4% to $44.18 after falling over 5% on Friday.</li>
<li><strong>MGE Energy, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgee#NASDAQ">MGEE</a>) rose 12% to $70.75. MGE Energy will replace iRobot in the S&amp;P SmallCap 600.</li>
<li><strong>BGC Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgc#NASDAQ">BGC</a>) gained 11.8% to $7.93. BGC Group is set to join S&amp;P SmallCap 600.</li>
<li><strong>Jin Medical International Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) climbed 11.6% to $7.10.</li>
<li><strong>H&amp;R Block, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrb#NYSE">HRB</a>) gained 8.9% to $52.08.</li>
<li><strong>Aadi Bioscience, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aadi#NASDAQ">AADI</a>) shares surged 8.8% to $2.0899 after the company announced publication of long-term efficacy and safety data further supporting FYARRO&reg; for the treatment of malignant PEComa.</li>
<li><strong>MSP Recovery, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lifw#NASDAQ">LIFW</a>) shares rose 7.7% to $1.11. LifeWallet announced a comprehensive settlement with 28 affiliated property and casualty insurers, benefiting LifeWallet&rsquo;s <a href="https://www.benzinga.com/money/best-medicare-advantage-plans/">medicare</a> clients across the U.S.</li>
<li><strong>Coinbase Global, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) climbed 7.5% to $221.11 amid a rise in the price of Bitcoin.</li>
<li><strong>Box, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/box#NYSE">BOX</a>) gained 6.6% to $28.30. Box will replace Forrester Research Inc in the S&amp;P SmallCap 600.</li>
</ul>
<h3><strong>Losers</strong></h3>
<ul>
<li><strong>BioVie Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) fell 42.7% to $1.0830 after the company reported pricing of public offering.</li>
<li><strong>JOANN Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/joan#NASDAQ">JOAN</a>) fell 38.7% to $ .3102&nbsp;following a report suggesting the company may file for bankruptcy soon.</li>
<li><strong>Astra Space, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astr#NASDAQ">ASTR</a>) dipped 35% to $0.8598.</li>
<li><strong>BioCardia, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcda#NASDAQ">BCDA</a>) fell 23.3% to $0.4449 after reporting interim results from Phase III CardiAMP cell therapy heart failure trial.</li>
<li><strong>MMTec, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) declined 21.8% to $2.00.</li>
<li><strong>Vivani Medical, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vani#NASDAQ">VANI</a>) declined 21.7% to $2.4199. Vivani Medical recently announced the pricing of a $15 million registered direct offering of common stock and warrants.</li>
<li><strong>Interactive Strength Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnr#NASDAQ">TRNR</a>) tumbled 19.8% to $0.40. Interactive Strength recently announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR.</li>
<li><strong>Infobird Co., Ltd </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) dipped 19.3% to $5.03</li>
<li><strong>Minim, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) fell 18.4% to $4.7395 after jumping 35% on Friday.</li>
<li><strong>Avidity Biosciences, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rna#NASDAQ">RNA</a>) fell 16.6% to $16.78. Avidity Biosciences announced new long-term AOC 1001 data from the Marina-OLE trial showing reversal of disease progression in Myotonic Dystrophy Type 1 patients across multiple endpoints.</li>
<li><strong>Playtika Holding Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pltk#NASDAQ">PLTK</a>) fell 14.8% to $6.44</li>
<li><strong>Aptevo Therapeutics Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apvo#NASDAQ">APVO</a>) declined 14.7% to $0.1399.</li>
<li><strong>J-Long Group Limited </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jl#NASDAQ">JL</a>) shares dipped 14.3% to $1.98 after jumping over 15% on Friday. J-Long Group recently declared a special cash dividend in aggregate amount of $6 million.</li>
<li><strong>Sunshine Biopharma, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) fell 14.3% to $0.0474. Sunshine Biopharma, last month, announced closing of $10.0 million underwritten public offering.</li>
<li><strong>New York Community Bancorp, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) fell 13.6% to $3.0650 after the company announced that it identified material weaknesses in its internal controls related to internal loan review, that resulted from ineffective oversight, risk assessment and monitoring activities.</li>
<li><strong>Spirit Airlines, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) fell 12.1% to $5.68 after the company announced the termination of its merger agreement with JetBlue.</li>
<li><strong>Sabre Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sabr#NASDAQ">SABR</a>) fell 11.6% to $2.3050. Sabre announced exchange of $150 million of existing 4.000% exchangeable senior notes due 2025 for exchangeable senior notes due 2026.</li>
<li><strong>Li Auto Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) fell 11.6% to $38.49. B of A Securities analyst Ming Hsun Lee maintained Li Auto with a Buy and raised the price target from $57 to $60.</li>
<li><strong>Revance Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) fell 11.2% to $6.20. Revance announced pricing of $100 million public offering of 16 million shares of common stock at a price of $6.25 per share.</li>
<li><strong>Beyond Meat, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) dipped 11.3% to $8.67 after the company announced that it was unable to file its annual report due to technical difficulties in assembling the submission for filing. Also, the company said it anticipates it will seek to raise additional capital in 2024.</li>
<li><strong>Caledonia Mining Corporation Plc </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcl#NASDAQ">CMCL</a>) shares tumbled 9.6% to $9.29 after the company issued a trading update for the year ended Dec. 31, 2023.</li>
<li><strong>Hertz Global Holdings, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/htz#NYSE">HTZ</a>) fell 7.2% to $7.26.</li>
<li><strong>NIO Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) fell 6.9% to $5.38.</li>
</ul>
<p>&nbsp;</p>
<p>Now Read This: <a href="	https://www.benzinga.com/trading-ideas/long-ideas/24/03/37454953/charles-colvard-and-3-other-penny-stocks-insiders-are-buying"><em> Charles &amp; Colvard And 3 Other Penny Stocks Insiders Are Buying </em></a></p>


AADI

AIMD

AKRO

APVO

ASTR

BBAI

BCDA

BIVI

CMCL

CRDF

CRML

DWAC

ETNB

FUFU

HSDT

IFBD

JAGX

LIFW

MGEE

MINM

NKTR

NYCB

OCEA

PHUN

PLTK

QNRX

RELI

RENB

RNLX

RVNC

SABR

SAVE

SBFM

TRNR

VANI

ZJYL

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

<p>U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.</p>
<p>Shares of <strong> Tesla, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) fell during Monday&rsquo;s session after the company reportedly saw a <a href="https://www.benzinga.com/markets/asia/24/03/37451229/why-tesla-shares-are-down-over-1-premarket-today">decline in February China sales.</a></p>
<p>Tesla sold 60,365 electric vehicles made in China in February, according to preliminary data released by the China Passenger Car Association, as reported by CnEVPost. The breakdown between exports and domestic sales will be available when the detailed report is released in a week.</p>
<p>Tesla shares fell 5.4% to $191.79 on Monday.</p>
<p>Here are some other big stocks recording losses&nbsp;in today&rsquo;s session.</p>
<ul>
<li><strong>MMTec, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) shares fell 21.8% to $2.00.</li>
<li><strong>Avidity Biosciences, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rna#NASDAQ">RNA</a>) declined 16.6% to $16.78. Avidity Biosciences announced new long-term AOC 1001 data from the Marina-OLE trial showing reversal of disease progression in Myotonic Dystrophy Type 1 patients across multiple endpoints.</li>
<li><strong>Playtika Holding Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pltk#NASDAQ">PLTK</a>) tumbled 14.8% to $6.44</li>
<li><strong>New York Community Bancorp, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) declined 13.6% to $3.0650 after the company announced that it identified material weaknesses in its internal controls related to internal loan review, that resulted from ineffective oversight, risk assessment and monitoring activities.</li>
<li><strong>Spirit Airlines, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) dipped 12.1% to $5.68 after the company announced the termination of its merger agreement with JetBlue.</li>
<li><strong>Lyell Immunopharma, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyel#NASDAQ">LYEL</a>) fell 12.1% to $2.70.</li>
<li><strong>Sabre Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sabr#NASDAQ">SABR</a>) declined 11.6% to $2.3050. Sabre announced exchange of $150 million of existing 4.000% exchangeable senior notes due 2025 for exchangeable senior notes due 2026.</li>
<li><strong>Li Auto Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) tumbled 11.6% to $38.49. B of A Securities analyst Ming Hsun Lee maintained Li Auto with a Buy and raised the price target from $57 to $60.</li>
<li><strong>Revance Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) dipped 11.2% to $6.20. Revance announced pricing of $100 million public offering of 16 million shares of common stock at a price of $6.25 per share.</li>
<li><strong>Beyond Meat, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) shares fell 11.3% to $8.67 after the company announced that it was unable to file its annual report due to technical difficulties in assembling the submission for filing. Also, the company said it anticipates it will seek to raise additional capital in 2024.</li>
<li><strong>Cytek Biosciences, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctkb#NASDAQ">CTKB</a>) fell 11.1% to $8.14. Cytek Biosciences filed for non-timely 10-K with the U.S. SEC.</li>
<li><strong>Sana Biotechnology, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sana#NASDAQ">SANA</a>) fell 10.8% to $10.04. Sana Biotechnology recently reported a year-over-year increase in quarterly financial results.</li>
<li><strong>ADS-TEC Energy PLC</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adse#NASDAQ">ADSE</a>) fell 10.5% to $9.71.</li>
<li><strong>ACM Research, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acmr#NASDAQ">ACMR</a>) declined 10.6% to $30.32.</li>
<li><strong>EyePoint Pharmaceuticals, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eypt#NASDAQ">EYPT</a>) fell 9.5% to $25.33. EyePoint Pharmaceuticals announced appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer.</li>
<li><strong>Omeros Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omer#NASDAQ">OMER</a>) fell 9.3% to $4.3350.</li>
<li><strong>iRhythm Technologies, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irtc#NASDAQ">IRTC</a>) tumbled 9% to $109.64. iRhythm announced a proposed offering of $450 million of convertible senior notes.</li>
<li><strong>Hertz Global Holdings, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/htz#NYSE">HTZ</a>) dipped 7.2% to $7.26.</li>
<li><strong>NIO Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) declined 6.9% to $5.38.</li>
<li><strong>Rivian Automotive, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>) fell 6.8% to $10.58.</li>
<li><strong>Victoria&#39;s Secret &amp; Co.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsco#NYSE">VSCO</a>) fell 5.8% to $26.77.</li>
<li><strong>Unity Software Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/u#NYSE">U</a>) fell 5.3% to $27.36.</li>
</ul>
<p>&nbsp;</p>
<p>Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37458044/bitcoin-surpasses-65-000-pepe-emerges-as-top-gainer"><em> Bitcoin Surpasses $65,000; Pepe Emerges As Top Gainer</em></a></p>


ADSE

CTKB

EYPT

IRTC

LYEL

OMER

SANA

TSLA

VSCO

Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday

Beyond Meat shares are trading lower after the company announced that it was unable to file its annual report due to technical difficulties in assembling the submission for filing. Also, the company said it anticipates it will seek to raise additional capital in 2024.

<p>Beyond Meat, Inc., a Delaware corporation (the "Company"), was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "Form 10-K") by the prescribed deadline of 5:30 p.m. (ET) on February 29, 2024 due to technical difficulties in assembling the submission for filing. The Company expects to file the Form 10-K as soon as possible, but no later than March 15, 2024, the fifteenth calendar day following the prescribed due date of the Form 10-K.</p>
<p><br />&nbsp;</p>


Earnings

Beyond Meat Was Unable To File Its Annual Report On Form 10-K For The Fiscal Year Ended December 31, 2023 By February 29, 2024 Due To Technical Difficulties In Assembling The Submission For Filing. Co Expects To File The Form 10-K As Soon As Possible, But No Later Than March 15, 2024

Beyond Meat shares are trading higher on continued strength after the company recently reported Q4 financial results.

<p>Financial giants have made a conspicuous bullish move on Beyond Meat. Our analysis of options history for Beyond Meat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 60% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $348,760, and 4 were calls, valued at $225,280.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $7.0 and $40.0 for Beyond Meat, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Beyond Meat's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Beyond Meat's substantial trades, within a strike price spectrum from $7.0 to $40.0 over the preceding 30 days.</p>
<h3>Beyond Meat Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1709226088_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/19/24</td>
<td>$8.00</td>
<td>$119.0K</td>
<td>6.3K</td>
<td>306</td>
</tr>
<tr>
<td>BYND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/19/24</td>
<td>$8.00</td>
<td>$112.3K</td>
<td>4.7K</td>
<td>474</td>
</tr>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/19/24</td>
<td>$7.00</td>
<td>$71.6K</td>
<td>3.2K</td>
<td>3.4K</td>
</tr>
<tr>
<td>BYND</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/15/24</td>
<td>$15.00</td>
<td>$51.6K</td>
<td>311</td>
<td>82</td>
</tr>
<tr>
<td>BYND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/15/24</td>
<td>$9.00</td>
<td>$48.4K</td>
<td>1.3K</td>
<td>563</td>
</tr>
</tbody>
</table>
</p>
<h3>About Beyond Meat</h3>
<p>Beyond Meat Inc is a provider of plant-based meats, such as burgers, sausage, ground beef, and chicken. Unlike other vegetarian products, Beyond Meat seeks to replicate the look, cook, and taste of meat targeted to omnivores and vegetarians alike and is sold in the meat case. The products are widely available across the U.S. and Canada and in 83 additional countries as well. International revenue represented 31% of 2021 sales. The firm's products are available in retail stores and the food service channel. In 2019, before the pandemic struck, sales were evenly split between these two channels, although the mix stood at 70% retail/30% food service in 2021. We think the recovery from the crisis and new deals with McDonald's and Yum Brands will return food-service sales to 50% in time.</p>
<p>In light of the recent options history for Beyond Meat, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Beyond Meat Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 6,528,147, the BYND's price is down by -3.36%, now at $9.5. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 69 days.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Beyond Meat, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Spotlight on Beyond Meat: Analyzing the Surge in Options Activity

Beyond Meat says new versions of Beyond Burger and Beyond Beef are preferred by consumers

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Stocks, even fundamentally strong ones, can plunge for any number of reasons. The chances that fundamentally weak stocks plunge are much higher.&nbsp;Since the value of a company&rsquo;s shares is directly tied to both its business model and performance, lacking this stability poses a significant financial risk.</p>



<p>Moreover, the companies discussed in this article were once surrounded by much more optimism. As market trends shift, so too has public opinion around these companies. Today, these firms exist in former growth industries that have since seen their fortunes reverse. Others represent firms that gained fame due to the emergence of memes and meme stock mania. Regardless of their origin, investors would do well to avoid these firms.</p>



<p>Fundamental strength should be the primary determining factor when selecting investment-worthy stocks. Bearing this in mind, the firms discussed below represent some of the riskiest stocks to avoid.</p>



<h2>ChargePoint (CHPT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/chpt1600-300x169.png" alt="Selective focus. Detail of ChargePoint commercial EV electric vehicle charging station on uncovered parking lot. CHPT stock"><div>Source: Michael Vi / Shutterstock.com</div></div><p>Rewind a few years and<strong> ChargePoint</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/chpt-stock-quote/"><strong>CHPT</strong></a></span>)&nbsp; stock looked like it was going to be a major winner. The firm even continues to operate one of the largest charging networks in the United States. Many assumed that its strong early position would allow the company to build an unassailable lead as the electric vehicle (EV) market boomed. However, that hasn&rsquo;t been the case.</p>



<p>The EV market continues to grow although at a stunted pace. ChargePoint, on the other hand, is contracting. <a href="https://investors.chargepoint.com/news/news-details/2024/ChargePoint-Reports-Fourth-Quarter-and-Full-Fiscal-Year-2024-Financial-Results/default.aspx">Revenues declined by 24%</a> in the fourth quarter, falling to $115.8 million. Margins concurrently fell by 3%. The combination of those two factors is overtly negative and should provide a strong enough basis for investors to avoid the stock.&nbsp;</p>



<p>The company has given guidance for positive EBITDA figures by early 2025. I strongly suspect that investors, many of whom have already been burned by <a href="https://investorplace.com/industries/consumer-discretionary/automotive/electric-vehicles/">EV stocks</a>, are unwilling to move on that forecast. Furthermore, EBITDA doesn&rsquo;t include the effects of interest, taxes, depreciation and amortization all of which contribute to overall net income. It&rsquo;s clear that the company does not expect profitability on a net income basis by that same time. Overall, these patterns are common among stocks to avoid owning.&nbsp;</p>



<h2>Beyond Meat (BYND)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/bynd-stock-1-300x169.jpg" alt=""><div>Source: Shutterstock</div></div><p>Investors need only take a look at the <a href="https://investors.beyondmeat.com/news-releases/news-release-details/beyond-meatr-reports-fourth-quarter-and-full-year-2023-financial">most recent earnings report </a>of<strong> Beyond Meat</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/bynd-stock-quote/"><strong>BYND</strong></a></span>) in&nbsp;order to understand why its stock is one to avoid.</p>



<p>The company lost $338.1 million in net income in 2023 as sales declined by 18%. Beyond Meat can&rsquo;t even figure out how to profitably manufacture and sell its plant-based burgers. That&rsquo;s evident in the $82.7 million gross loss incurred throughout 2023. The cost of sales is simply too high. That&rsquo;s a particularly bad problem and compounded by the fact that product sales have also dropped.</p>



<p>Things aren&rsquo;t getting better for the company either. During the fourth quarter, net loss reached $155 million. It continues to be crystal clear that Beyond Meat does not have a strong business overall despite being a prominent name in the plant-based meat industry. There is a certain irony given the fact that the <a href="https://www.globenewswire.com/en/news-release/2024/01/23/2814067/0/en/Plant-Based-Meat-Market-Valuation-to-Reach-USD-35-1-Billion-by-2032-Driven-by-18-5-CAGR-Market-us.html">forecast for that sector remains strong even in 2024</a>. Beyond Meat got into the right opportunity at the right time but for a variety of other factors couldn&rsquo;t make it work.&nbsp;</p>



<h2>GameStop (GME)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/11/gme-stock-4-300x169.jpg" alt="An empty GameStop (GME) store in Dresden, Germany."><div>Source: 1take1shot / Shutterstock.com</div></div><p><strong>GameStop</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/gme-stock-quote/"><strong>GME</strong></a></span>) stock is no longer worth touching. That isn&rsquo;t to say that I&rsquo;ve truly ever believed that it was worth touching. I haven&rsquo;t. I continue to scratch my head at its ascendance but remain firm in my conviction that it will ultimately fail.&nbsp;</p>



<p>In my opinion, a lot of people who still have faith in GME stock convince themselves that recent profitability matters. The truth is GameStop&rsquo;s earnings were lower than anticipated although positive. Revenues were <a href="https://www.barrons.com/articles/gamestop-earnings-stock-price-489eef2e">more than $200 million lower than analysts had been expecting</a>. Yet, many fans of GME stock will point to the fact that the company did provide earnings. They will use that truth to substantiate an opinion that GameStop has some sort of ability to rebound.</p>



<p>I don&rsquo;t believe that&rsquo;s the case because GameStop is a relic of a dying era. The company lacks the digital strategy necessary to succeed in the current gaming environment. Game downloads rule, physical disc sales do not.</p>



<p><em>On the date of publication, Alex Sirois did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em> Publishing Guidelines</em></a><em>.</em></p>
<div><p>Alex Sirois is a freelance contributor to InvestorPlace whose personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks. Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/3-stocks-no-one-in-their-right-mind-would-own-right-now/">3 Stocks No One in Their Right Mind Would Own Right Now</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Stocks No One in Their Right Mind Would Own Right Now

Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>With recent trends centered not only around the health of humans but of our planet and all its inhabitants, vegan diets are more popular than ever. Plant substitutes for meat are just the beginning as plant-based, vegan-friendly foods are becoming available in stores, restaurants, and public institutions like schools.&nbsp;As you may expect, companies that provide vegan-friendly food choices prosper, with veganism on the rise. These three vegan stocks to buy now represent a culmination of the vegan market through vegan-friendly food products and the technology that goes into making them.&nbsp;</p>



<p>We&rsquo;ll detail these stocks&rsquo; latest financial reports, their latest contributions to the vegan market, and their future potential, which makes them excellent buys for this quarter.</p>



<h2><strong>Beyond Meat (BYND)</strong></h2>



<p><strong>Beyond Meat </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/bynd-stock-quote/"><strong>BYND</strong></a></span>) is the largest and most well-known producer of meat-substitute food products. The typical vegan options available at stores and restaurants are likely Beyond Meat products. In March 2023, the company reported its products were <a href="https://investors.beyondmeat.com/news-releases/news-release-details/beyond-steakr-1-new-plant-based-meat-item-retail-now-available#:~:text=As%20of%20March%202023%2C%20Beyond,in%20over%2080%20countries%20worldwide.">available</a> in 191,000 retail and food service outlets in over 80 countries worldwide.</p>



<p>Beyond Meat saw a huge <a href="https://www.macrotrends.net/stocks/charts/BYND/beyond-meat/revenue">revenue</a> boom leading up to COVID-19, but after the economic slowdown, the company suffered and has yet to reach its historic heights again. The stock has dipped below the profit line, and the margin widened last year following a global operations review. However, Beyond Meat is by no means down for the count.</p>



<p>One primary reason for Beyond Meat&rsquo;s extensive spending this last year is the company&rsquo;s continued efforts in research and development, which allow it to stay ahead in the meat-substitute market. Beyond Meat recently launched the fourth generation of <a href="https://www.beyondmeat.com/en-US/press/beyond-iv-the-fourth-generation-of-the-beyond-burger-and-beyond-beef-debuts-at-grocery-stores-across-the-u-s-including-at-walmart-and-kroger">Beyond Burger</a>, one of its most popular products.</p>



<p>This product alone will undoubtedly be a huge revenue driver for Beyond Meat and the many other upcoming launches. Investors can take advantage of Beyond Meat&rsquo;s current low price and watch it grow along with the rising popularity of veganism.</p>



<h2><strong>Local Bounti (LOCL)</strong></h2>



<p><strong>Local Bounti </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/locl-stock-quote/"><strong>LOCL</strong></a></span>) offers investors interested in vegan stocks a unique opportunity. The company is a fresh, young agricultural tech company that is bringing innovations to the world of agriculture. One example of Local Bounti&rsquo;s tech is its patented &ldquo;<a href="https://investors.localbounti.com/news-events/press-releases/detail/65/local-bounti-receives-patent-for-stack-flow-technology">stack and flow</a>&rdquo; farming system.</p>



<p>Local Bounti&rsquo;s mission is to utilize technology to discover and adopt more sustainable farming methods. With stack and flow, the company claims to use 90% less water and 90% less land than conventional methods. In addition to the growing popularity of veganism, Local Bounti&rsquo;s goals align with the more modern focus on sustainability and eco-friendly technology.&nbsp;</p>



<p>Local Bounti released its earnings for 2023 in late March. The <a href="https://investors.localbounti.com/news-events/press-releases/detail/67/local-bounti-announces-full-year-2023-financial-results">results</a> were promising. Local Bounti reported a solid increase in production volume, with its Georgia facility producing 50% more packed pounds than in December 2023. Preliminary results for Q1 of this year also included a 22% revenue jump.&nbsp;</p>



<p>The report includes other promising details, such as the company&rsquo;s Texas and Washington facilities&rsquo; shipment start date in Q2. These facilities&rsquo; contributions will be accompanied by a reported $228 million confirmed <a href="https://investors.localbounti.com/news-events/press-releases/detail/67/local-bounti-announces-full-year-2023-financial-results">financing</a> for new projects this year.&nbsp;</p>



<p>Investors should take advantage of Local Bounti now while it is still under the radar. Massive financing and a Q2 shipping network expansion will certainly make this stock prosperous in the year ahead.</p>



<h2><strong>Mission Produce (AVO)</strong></h2>



<p><strong>Mission Produce </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/avo-stock-quote/"><strong>AVO</strong></a></span>) is one of the largest suppliers of Avocados and has a pervasive network with over <a href="https://missionproduce.com/news/mission-produce-launches-here-for-good-campaign-in-celebration-of-40-year-anniversary#">14,000 </a>acres scattered across the globe. Avocados are a trendy choice for vegans but are also used heavily to produce ingredients such as avocado oil, which is common in vegan cooking and other products.</p>



<p>Mission Produce suffered from the drop in avocado <a href="https://fred.stlouisfed.org/series/WPU01110205">prices</a> and production limitations caused by COVID-19. However, the company has been among the first to bounce back and restore its business to near pre-COVID levels.</p>



<p>Avocado prices are back on the rise and will undoubtedly mean great things for Mission Produce in Q2 and the rest of this year. So far this year, Mission Produce reported a <a href="https://investors.missionproduce.com/news-releases/news-release-details/mission-producetm-announces-fiscal-2024-first-quarter-financial">stellar Q1</a> with a 21% revenue increase and an adjusted net income of $6.7 million.&nbsp;</p>



<p>Avocados will always stay in style with veganism, so this stock represents a solid choice for investors looking to take advantage of this growing dietary trend.</p>



<p><em>On the date of publication, Joel Lim did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em></p>



<p></p>
<div><p>Joel Lim is a finance freelance writer who writes content for several companies like LTSE and Realtor, along with financial publications, including Mises Institute and Foundation for Economic Education.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/04/3-vegan-stocks-to-buy-now-q2-edition/">3 Vegan Stocks to Buy Now: Q2 Edition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Vegan Stocks to Buy Now: Q2 Edition

Leaven Partners - Laird Superfood: Our Largest Positive Contributor

Wall Street Breakfast: The Week Ahead

Beyond Meat (BYND) just unveiled an announcement. Beyond Meat, Inc. has appointed Yi (Jevy) Luo as their new principal accounting officer, bringing...

Beyond Meat Welcomes New Principal Accounting Officer

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>As concerns <a href="https://unctad.org/news/global-economic-growth-set-slow-26-2024-just-above-recession-threshold">about a global recession grow</a>, it might be wise to consider divesting from certain Nasdaq stocks to sell. The <strong>Nasdaq</strong> is known for hosting a range of innovative tech companies. However, not all of these align with traditional market strengths. Specifically, some publicly traded companies on the exchange present a dual challenge: they are both high-risk and overvalued.</p>



<p>Given that the topic of selling Nasdaq stocks can be sensitive, I will focus this discussion on financial data. You might not agree with this analysis, and that&rsquo;s perfectly acceptable. Indeed, the diversity of opinions is what enriches the free market. The aim of this article is to highlight specific companies that exhibit fundamental weaknesses.</p>



<p>I considered these Nasdaq stocks to sell due to a mix of their free cash flow problems, debt issues, competitive weaknesses, and overall risky and unfavorable positions. We&rsquo;ve been on a historic bull market for the last couple of years. Furthermore, I think these companies will be the first to take a large hit when the market inevitably corrects itself.</p>



<p>So here are three Nasdaq stocks to sell for this month.</p>



<h2>Canopy Growth (CGC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/cgc1600-300x169.jpg" alt="The Canopy Growth (CGC) website is open in an internet browser tab."><div>Source: Jarretera / Shutterstock.com</div></div><p>As my colleague Joel Baglole wrote recently, <strong>Canopy Growth</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgc-stock-quote/"><strong>CGC</strong></a>) has been posting significant losses. Its stock price has been dramatically declining over the past years. Ongoing financial struggles and shrinking market share make its future uncertain&#8203;.</p>



<p>Looking ahead, <a href="https://www.marketbeat.com/stocks/NASDAQ/CGC/price-target/">analysts have a conservative outlook</a> on CGC&rsquo;s stock, with current price targets suggesting a potential downside. The consensus price target is around $4.87, indicating a 38% decrease from the current levels.</p>



<p>However, I think that things are worse than they appear for CGC.</p>



<p>CGC recorded nearly a billion dollars in losses over the last 12 months. It only has $140 <a href="https://stockanalysis.com/stocks/cgc/forecast/">million of cash</a> on its balance sheet. Furthermore, it already has nearly half a billion dollars of debt, too. The debt stands at $446 million, a huge sum for a company whose EPS has consistently been negative.</p>



<p>CGC has also undergone a massive shareholder dilution, with shares outstanding growing 70.58% year-over-year.</p>



<p>I think that even if CGC is somehow able to remain solvent, this dilution will continue at the expense or shareholders. At the minimumm its financial risk profile will increase, which then makes it one of those Nasdaq stocks to sell.</p>



<h2>Beyond Meat (BYND)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/bynd1600-1-1-300x169.png" alt="Editorial photo on Beyond Meat (BYND) theme. Illustrative photo for news about Beyond Meat - a producer of plant-based meat substitutes. BYND stock"><div>Source: photo_gonzo / Shutterstock.com</div></div><p><strong>Beyond Meat</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bynd-stock-quote/"><strong>BYND</strong></a>) has seen its stock price plummet as losses mount and sales continue to decline.</p>



<p>Analysts have taken a bearish stance on BYND, as it has a &ldquo;<a href="https://stockanalysis.com/stocks/bynd/forecast/">Sell</a>&rdquo; consensus rating, and EPS profitability is not expected to be reached in the foreseeable future.</p>



<p>The full-year forecast is set at $315-345 million, <a href="https://dexwirenews.com/beyond-meat-nasdaq-bynd-q4-exceeds-expectations-2024-outlook-dampens-growth-prospects/">below the $343.8 million consensus</a>. Despite a steep 24.1% negative gross margin in 2023, BYND aims to reach mid-to-high margins in 2024, with improvements expected in the latter half of the year.</p>



<p>Significant budget cuts of $70 million are planned for 2024, alongside efforts to optimize its manufacturing processes and adjust pricing strategies to support margin expansion.</p>



<p>However, I&rsquo;m not sure this is enough to support BYND&rsquo;s business moving forward. It has less than two years worth of cash on its balance sheet per its current rate of cash burn, and already has more than one billion dollars worth of debt.&nbsp;</p>



<p>BYND has an interesting premise, but I think it&rsquo;s time for management to front up that it poses too much risk for investors to assume.</p>



<h2>QuantumScape (QS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/01/quantumscape-qs-stock-1600-300x169.jpg" alt="The entrance to QuantumScape Headquarters QS stock"><div>Source: Tada Images / Shutterstock.com</div></div><p><strong>QuantumScape</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/qs-stock-quote/"><strong>QS</strong></a>)&nbsp; involved in developing solid-state batteries for electric vehicles, has faced skepticism about its technology&rsquo;s viability and timeline</p>



<p><br>QS has no revenue or earnings, and has around three years worth of cash on its balance sheet before it must raise capital again, assuming all else being equal.</p>



<p>The dream of QS is being kept alive by some very optimistic projections from Wall Street, this includes its revenue <a href="https://stockanalysis.com/stocks/qs/forecast/">surging to 1.38 billion</a> in FY2028, and a steadily improving bottom line.</p>



<p>The problem is that these predictions are incredibly optimistic. It&rsquo;s making a lot of assumptions about the viability of its business model, the success of its research team, the market&rsquo;s adoption of QS&rsquo;s solution, and so on. Normally assumptions are made on past data from sales and earnings, as well as other factors. But since QS lacks this history, what we&rsquo;re left with is essentially opinion and speculation.&nbsp;</p>



<p>There many moving parts to the QS stock thesis, and any one of those parts, including unforeseen one&rsquo;s going wrong can throw a spanner in the works severely, thus making it one of those highly risky Nasdaq stocks to sell, that are interesting nonetheless.</p>



<p>For 2024, <a href="https://www.investing.com/news/stock-market-news/earnings-call-quantumscape-advances-in-solidstate-battery-development-93CH-3304573">QS plans to begin low-volume production</a> of its QSE-5 prototype batteries, with expectations to ramp up to higher volumes in 2025. The company anticipates capital expenditures to range between $70 million and $120 million for the year, with an adjusted EBITDA loss projected between $250 million to $300 million.&nbsp;</p>



<p><em>On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em> </em>InvestorPlace.com Publishing Guidelines</a>.</p>
<div><p>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/3-nasdaq-stocks-that-could-be-heading-six-feet-under/">3 Nasdaq Stocks That Could Be Heading Six-Feet Under</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Nasdaq Stocks That Could Be Heading Six-Feet Under

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Volatility is rising in the stock market. Between the recent hot inflation data and mounting geopolitical tensions, investors are starting to reassess the broader economic environment. </p>



<p>It seems that the Federal Reserve might not come through with previously anticipated interest rate cuts. This, in turn, has the potential to greatly reduce the speculative juices in the stock market. Throw in some softness in leading <a href="https://investorplace.com/industries/technology/artificial-intelligence/">AI stocks</a>, and the market&rsquo;s red flags are mounting.</p>



<p>Investors should be repositioning their portfolios accordingly. Some of the companies at highest risk today are those that have weak fundamentals. Rather, their shares have found support primarily due to meme trading, short squeezes and other such exogenous factors. </p>



<p>But the stock market&rsquo;s bull run is now in danger. It&rsquo;s time to throttle back risk exposure, making it an opportune moment to sell these three <a href="https://investorplace.com/stock-types/meme-stocks/">meme stocks</a> before they utterly implode like <strong>AMC Entertainment</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/amc-stock-quote/"><strong>AMC</strong></a></span>).</p>



<h2>Carvana (CVNA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/11/cvna1600-300x169.png" alt="Carvana (CVNA) automobile dealership vending machine. Carvana is an online-only used car dealer."><div>Source: Ken Wolter / Shutterstock.com</div></div><p><strong>Carvana</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/cvna-stock-quote/"><strong>CVNA</strong></a></span>) has had a breathtaking run over the past year with this stock rising approximately 700%. Simply incredible stuff. </p>



<p>Unfortunately, there&rsquo;s scant little fundamental cause to justify a move of any such magnitude. Carvana, as a retailer with its unique car vending machines, has created a distinct marketplace for used cars. It also purchases used vehicles directly from individuals, sometimes at <a href="https://www.theverge.com/22923871/carvana-pandemic-used-car-prices-sold-online-chip-shortage">surprisingly high prices</a>.</p>



<p>If operated judiciously, this business model might be a winner. But, the issue is that the firm is incredibly levered and barely profitable. In fact, it had to fight off <a href="https://www.cnbc.com/2024/02/02/carvana-leaner-and-ready-for-wall-street-redemption.html">bankruptcy concerns</a> not too long ago. Carvana barely squeezed out a small profit last year despite an exceptionally favorable car market and elevated levels of consumer spending.</p>



<p>Given high interest rates and the potential for significantly declining consumer discretionary spending, it seems Carvana probably has already enjoyed the best market conditions it could hope for. If it couldn&rsquo;t squirrel away large profits when the sun was shining, a storm could devastate the firm. Things are likely to get worse from here, and analysts agree. They model Carvana falling back into <a href="https://seekingalpha.com/symbol/CVNA/earnings/estimates">loss-making territory</a> this year. Furthermore, analysts expect Carvana to generate large losses in 2025 and 2026 as well.</p>



<p>In addition, the stock has been bolstered by a massive short squeeze. <a href="https://www.benzinga.com/quote/CVNA/short-interest">32% of the float</a> has been sold short and that&rsquo;s rocket fuel on the way up. But this factor could lead to an equally rapid descent when momentum runs in reverse. </p>



<h2>Beyond Meat (BYND)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/10/bynd1600-300x169.png" alt="Person holding mobile phone with logo of American meat substitute company Beyond Meat Inc. (BYND) on screen in front of web page. Focus on phone display. Unmodified photo."><div>Source: T. Schneider / Shutterstock.com</div></div><p>Years ago, <strong>Beyond Meat</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/bynd-stock-quote/"><strong>BYND</strong></a></span>) was a hot new IPO that sought to revolutionize the protein market. Many people thought plant-based burgers and sausages would be a serious competitive threat to traditional animal meats as time went on. </p>



<p>This is becoming increasingly less likely. Beyond Meat&rsquo;s partnerships with restaurants largely <a href="https://www.cnbc.com/2022/07/28/beyond-meat-stock-falls-after-conclusion-of-mcdonalds-mcplant-test.html">failed</a> to move the needle. Sales at grocery stores have also <a href="https://www.thestreet.com/restaurants/beyond-meat-responds-to-low-sales-and-customers-may-not-like-it">declined</a> as Beyond Meat has struggled to find traction outside of its dedicated, but small, vegan and vegetarian fanbase.</p>



<p>Simply put, alternative proteins haven&rsquo;t found the right product, quality and price mix to garner significant market adoption from omnivores. Beyond Meat has always had massive overhead and low operating margins, resulting in the company losing hundreds of millions of dollars per year.</p>



<p>That was somewhat acceptable when revenues were rising and Beyond Meat could hope to reach operating scale and overcome its financial travails. </p>



<p>Now, though, the bloom is off the rose. Beyond Meat&rsquo;s revenues plunged from $465 million in 2021 to just $343 million in 2023. Analysts expect another decline to $329 million in 2024.</p>



<p>BYND stock soared on <a href="https://investorplace.com/2024/02/why-is-beyond-meat-bynd-stock-up-62-today/">a short squeeze</a> earlier this year, but it&rsquo;s already given back those gains, and there&rsquo;s little fundamental reason for optimism. Traders should look to exit this meme stock before it goes from bad to worse.</p>



<h2>Joby Aviation (JOBY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/joby-stock-300x169.jpg" alt="A Joby Aviation (JOBY Stock) air taxi on display."><div>Source: T. Schneider / Shutterstock.com</div></div><p><strong>Joby Aviation</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/joby-stock-quote/"><strong>JOBY</strong></a></span>) is a venture stage company attempting to commercialize electric vehicles for short range flights. The idea is that passengers can use Joby vehicles to get from an airport to a destination close to their house or office, for example.</p>



<p>In theory, this sort of electric vehicle could transform the <a href="https://www.afar.com/magazine/what-exactly-are-air-taxis-and-where-are-they">urban taxi market</a>, at least on certain popular high-volume routes. However, it remains to be seen if these sorts of vehicles will be more commercially viable than helicopters. </p>



<p>Needless to say, private helicopters services have existed for decades and remain a niche. It seems there simply aren&rsquo;t that many consumers that have the money or the willingness to pay for short range private flights. </p>



<p>Joby and other eVTOL players are hoping that the electrification of the private aircraft will lead to adoption as it can address some noise and environmental concerns. But commercial proof of concept remains lacking. Additionally, short sellers have taken Joby to task <a href="https://investorplace.com/2023/10/kerrisdale-slams-joby-aviation-joby-stock-in-new-short-report/">citing concerns</a> both on the cost of the vehicles and with eventual passenger demand.</p>



<p>Despite having virtually no revenues and losing approximately $500 million per year, Joby retains a massive market capitalization. Simply put, a $3 billion market cap is a gigantic speculative bet on a company that may well not amount to much in the end. Put another way, traders should get out of JOBY stock before the broader economy turns downward and these sorts of highly speculative concept stocks totally implode.</p>



<p><em>On the date of publication, Ian Bezek did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.</em></p>
<div><p>Ian Bezek has written more than 1,000 articles for InvestorPlace.com and Seeking Alpha. He also worked as a Junior Analyst for Kerrisdale Capital, a $300 million New York City-based hedge fund. You can reach him on Twitter at @irbezek.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/3-meme-stocks-to-dump-in-april-before-they-become-the-next-amc/">3 Meme Stocks to Dump in April (Before They Become the Next AMC)</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Meme Stocks to Dump in April (Before They Become the Next AMC)

Catalyst Watch: Apple earnings, Viking IPO, Chinese EV deliveries and Russell indices' Rank Day